Log In
BCIQ
Print this Print this
 

Ixogel, azithromycin (SHB004)

  Manage Alerts
Collapse Summary General Information
Company Ixodes AG
Description10% topical azithromycin gel
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPhase III
Standard IndicationLyme disease
Indication DetailsPrevent Lyme disease
Regulatory Designation U.S. - Qualified Infectious Disease Program (Prevent Lyme disease);
U.S. - Special Protocol Assessment (Prevent Lyme disease)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today